NEW YORK--(BUSINESS WIRE)--
Bristol-Myers
Squibb Company (NYSE:BMY) will participate in the Cowen and Company
38th Annual Global Health Care Conference on Monday, March
12, 2018, in Boston. Giovanni
Caforio, chairman and chief executive officer and Fouad Namouni,
head of oncology development will answer questions about the company at
2:50 p.m. ET.
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com
or follow us on LinkedIn,
Twitter,
and YouTube.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180305005120/en/
Source: Bristol-Myers Squibb Company